DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20190752

Thyroid abnormalities among Down syndrome children from Kerala, India

Vijitha Viswambharan, Mahesh M. Vasu, Ismail Thanseem, Suresh A. Poovathinal, Ayyappan Anitha

Abstract


Down syndrome (DS), caused by trisomy of human chromosome 21, is one of the most common chromosomal abnormalities in live born infants with a prevalence rate of 1 in 700 live births. Individuals with DS usually have comorbid conditions such as thyroid dysfunction, growth retardation, diabetes mellitus and obesity. The most frequent among these are the thyroid abnormalities which range from subclinical to overt hypothyroidism, and rarely hyperthyroidism.1-3 Individuals with DS are more susceptible to thyroid disorders compared to the general population. Primary hypothyroidism, referred to as elevated TSH, is the most common thyroid abnormality in DS; secondary hypothyroidism indicated by normal/reduced TSH is extremely rare. The prevalence of hypothyroidism varies between 3-54% in adults with DS.4 The aim of this study was to examine the incidence of thyroid abnormalities among children with DS registered in a tertiary referral center for neurodevelopmental disorders and non-communicable neurological disorders in Kerala, a south Indian state. 100 children with DS in the age range of 4 months-15 years, registered at Institute for Communicative and Cognitive Neurosciences (ICCONS), Shoranur, Kerala during the period of 2012-2016, were recruited for the study. The mean age of the participants (57 males, 43 females) was 5.4±3.8 years. The diagnosis of DS was confirmed by karyotyping. All the participants were drug-naive at the time of blood collection. 500 µl of serum samples was used for thyroid function test (TFT) which measured the levels of TSH, triiodothyronine (T3) and thyroxine (T4) by chemiluminescence immunoassay (CLIA). The reference range for TSH, T3 and T4 were as follows, TSH: 0.4-4mIU/ml, T3: 70-170ng/dl, T4: 4.5-12.5mg/dl.

Keywords


CLIA, DS, TFT, TSH

Full Text:

PDF

References


Dayal D, Jain P, Panigrahi I, Bhattacharya A, Sachdeva N. Thyroid dysfunction in Indian Children with Down syndrome. Ind Pediatr. 2014;51:751-2.

Cebeci AN, Guven A, Yıldız M. Profile of hypothyroidism in Down’s Syndrome. J Clin Res Pediatr Endocrinol. 2013;5:116-20.

Moosa S, Segal DG, Christianson AL, Gregersen NE. Thyroid dysfunction in a cohort of South African children with Down syndrome. S Afr Med J. 2013;103:966-70.

Sharav T, Collins RM Jr, Baab PJ. Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin. Am J Dis Child. 1988;142:1302-6.

Gruneiro de Papendieck L, Chiesa A, Bastida MG, Alonso G, Finkielstain G, Heinrich JJ. Thyroid dysfunction and high thyroid stimulating hormone levels in children with Down’s syndrome. J Pediatr Endocrinol Metab. 2002;15:1543-8.

Oliveira AT, Longui CA, Calliari EP, Ferone Ede A, Kawaguti FS, Monte O. Evaluation of the hypothalamic–pituitary–thyroid axis in children with Down syndrome. J Pediatr Rio J. 2002;78:295-300.

Kaplowitz PB. Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol. 2010;2010(1):281453.

Walter KN, Corwin EJ, Ulbrecht J, Demers LM, Bennett JM, Whetzel C, et al. Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women. Thyroid Res. 2012;5:13.

Leung AM, Braverman LE, He X, Schuller KE, Roussilhes A, Jahreis KA, et al. Environmental Perchlorate and Thiocyanate Exposures and Infant Serum Thyroid Function. Thyroid 2012;22:938-43.

Kapelari K, Kirchlechner C, Högler W, Schweitzer K, Virgolini I, Moncayo R. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocr Disord. 2008;8:15.